Your browser doesn't support javascript.
loading
Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group.
Hibar, D P; Westlye, L T; Doan, N T; Jahanshad, N; Cheung, J W; Ching, C R K; Versace, A; Bilderbeck, A C; Uhlmann, A; Mwangi, B; Krämer, B; Overs, B; Hartberg, C B; Abé, C; Dima, D; Grotegerd, D; Sprooten, E; Bøen, E; Jimenez, E; Howells, F M; Delvecchio, G; Temmingh, H; Starke, J; Almeida, J R C; Goikolea, J M; Houenou, J; Beard, L M; Rauer, L; Abramovic, L; Bonnin, M; Ponteduro, M F; Keil, M; Rive, M M; Yao, N; Yalin, N; Najt, P; Rosa, P G; Redlich, R; Trost, S; Hagenaars, S; Fears, S C; Alonso-Lana, S; van Erp, T G M; Nickson, T; Chaim-Avancini, T M; Meier, T B; Elvsåshagen, T; Haukvik, U K; Lee, W H; Schene, A H.
Afiliação
  • Hibar DP; Imaging Genetics Center, Mark and Mary Stevens Institute for Neuroimaging & Informatics, University of Southern California, Marina del Rey, CA, USA.
  • Westlye LT; Janssen Research & Development, San Diego, CA, USA.
  • Doan NT; NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Jahanshad N; Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Cheung JW; Department of Psychology, University of Oslo, Oslo, Norway.
  • Ching CRK; NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Versace A; Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Bilderbeck AC; Imaging Genetics Center, Mark and Mary Stevens Institute for Neuroimaging & Informatics, University of Southern California, Marina del Rey, CA, USA.
  • Uhlmann A; Imaging Genetics Center, Mark and Mary Stevens Institute for Neuroimaging & Informatics, University of Southern California, Marina del Rey, CA, USA.
  • Mwangi B; Imaging Genetics Center, Mark and Mary Stevens Institute for Neuroimaging & Informatics, University of Southern California, Marina del Rey, CA, USA.
  • Krämer B; Neuroscience Interdepartmental Graduate Program, University of California, Los Angeles, Los Angeles, CA, USA.
  • Overs B; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Hartberg CB; University Department of Psychiatry and Oxford Health NHS Foundation Trust, University of Oxford, Oxford, UK.
  • Abé C; Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
  • Dima D; MRC Unit on Anxiety and Stress Disorders, Groote Schuur Hospital (J-2), University of Cape Town, Cape Town, South Africa.
  • Grotegerd D; UT Center of Excellence on Mood Disorders, Department of Psychiatry & Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Sprooten E; Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Germany.
  • Bøen E; Neuroscience Research Australia, Sydney, NSW, Australia.
  • Jimenez E; NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Howells FM; Department of Clinical Neuroscience, Osher Centre, Karolinska Institutet, Stockholm, Sweden.
  • Delvecchio G; Department of Psychology, City University London, London, UK.
  • Temmingh H; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Starke J; Department of Psychiatry, University of Münster, Münster, Germany.
  • Almeida JRC; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Goikolea JM; Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
  • Houenou J; Hospital Clinic, IDIBAPS, University of Barcelona, CIBERSAM, Barcelona, Spain.
  • Beard LM; Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
  • Rauer L; IRCCS "E. Medea" Scientific Institute, San Vito al Tagliamento, Italy.
  • Abramovic L; Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
  • Bonnin M; Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
  • Ponteduro MF; Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA.
  • Keil M; Hospital Clinic, IDIBAPS, University of Barcelona, CIBERSAM, Barcelona, Spain.
  • Rive MM; INSERM U955 Team 15 'Translational Psychiatry', University Paris East, APHP, CHU Mondor, Fondation FondaMental, Créteil, France.
  • Yao N; NeuroSpin, UNIACT Lab, Psychiatry Team, CEA Saclay, Gif Sur Yvette, France.
  • Yalin N; Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
  • Najt P; Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Germany.
  • Rosa PG; Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Redlich R; Hospital Clinic, IDIBAPS, University of Barcelona, CIBERSAM, Barcelona, Spain.
  • Trost S; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Hagenaars S; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany.
  • Fears SC; Program for Mood Disorders, Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Alonso-Lana S; Department of Psychiatry, Yale University, New Haven, CT, USA.
  • van Erp TGM; Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT, USA.
  • Nickson T; Centre for Affective Disorders, King's College London, London, UK.
  • Chaim-Avancini TM; Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.
  • Meier TB; Department of Psychiatry, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
  • Elvsåshagen T; Center for Interdisciplinary Research on Applied Neurosciences (NAPNA), University of São Paulo, São Paulo, Brazil.
  • Haukvik UK; Department of Psychiatry, University of Münster, Münster, Germany.
  • Lee WH; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany.
  • Schene AH; Division of Psychiatry, University of Edinburgh, Edinburgh, UK.
Mol Psychiatry ; 23(4): 932-942, 2018 04.
Article em En | MEDLINE | ID: mdl-28461699
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Substância Cinzenta Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Substância Cinzenta Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article